JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Scope & Guideline

Leading the way in infectious disease innovation.

Introduction

Immerse yourself in the scholarly insights of JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1525-4135
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1988 to 1994, from 1996 to 1997, from 1999 to 2024
AbbreviationJAIDS-J ACQ IMM DEF / JAIDS
Frequency15 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

JAIDS - Journal of Acquired Immune Deficiency Syndromes focuses on the comprehensive study of HIV/AIDS, emphasizing both clinical and epidemiological aspects. The journal seeks to disseminate research that advances the understanding of HIV/AIDS prevention, treatment, and management, with a commitment to addressing health disparities and improving outcomes for affected populations.
  1. Clinical Research:
    Investigates treatment regimens, drug efficacy, and patient outcomes related to antiretroviral therapy and other interventions for individuals living with HIV.
  2. Epidemiological Studies:
    Focuses on the patterns, causes, and effects of HIV infection in various populations, utilizing data to inform public health strategies.
  3. Behavioral and Social Sciences:
    Explores the impact of social determinants, stigma, and mental health on HIV prevention and treatment adherence.
  4. Innovative Prevention Strategies:
    Examines new approaches to HIV prevention, including pre-exposure prophylaxis (PrEP), vaccination studies, and community-based interventions.
  5. Intersection with Other Health Issues:
    Investigates the co-morbidities associated with HIV, including mental health, substance use, and chronic diseases that affect treatment and quality of life.
  6. Health Policy and Implementation Research:
    Studies the implementation of HIV care models and policies, aiming to improve access and quality of care for diverse populations.
JAIDS is at the forefront of emerging research trends in the field of HIV/AIDS, with a clear pivot towards addressing contemporary challenges faced by populations affected by HIV. The following themes have gained traction in recent publications, reflecting the evolving landscape of HIV research.
  1. Integration of Mental Health and HIV Care:
    There is an increasing focus on the intersection of mental health and HIV treatment, recognizing the importance of addressing psychological factors in improving health outcomes.
  2. Impact of COVID-19 on HIV Care:
    Research exploring how the COVID-19 pandemic has affected HIV testing, treatment adherence, and health outcomes is rapidly emerging, highlighting the need for resilient health systems.
  3. Use of Technology in HIV Prevention and Treatment:
    The incorporation of digital health solutions, telemedicine, and mobile health interventions to enhance HIV care and prevention efforts is a growing area of interest.
  4. Social Justice and Health Disparities:
    A rising trend in addressing social determinants of health, particularly the disparities experienced by marginalized communities in accessing HIV care and prevention.
  5. Long-Acting Antiretroviral Therapies:
    Research on long-acting injectable treatments and their implementation in various settings is becoming increasingly prominent, reflecting a shift towards more convenient treatment options.

Declining or Waning

While JAIDS has consistently published impactful research, certain themes appear to be waning or declining in prominence. This may reflect shifts in research focus, funding opportunities, or changes in public health priorities.
  1. Basic Science Research:
    There has been a noticeable decline in purely laboratory-based studies focusing on the molecular biology of HIV, as the journal shifts towards more applied clinical and public health research.
  2. HIV Vaccine Development:
    Research specifically dedicated to vaccine trials and related immunology studies has decreased, possibly due to the focus on therapeutic interventions and prevention strategies like PrEP.
  3. HIV Transmission Dynamics Modeling:
    Although still relevant, there appears to be less emphasis on theoretical modeling studies regarding HIV transmission dynamics, as the focus has shifted towards practical implementation of interventions.

Similar Journals

CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE

Elevating standards in public and environmental health research.
Publisher: SPRINGER INT PUBL AGISSN: 0008-4263Frequency: 6 issues/year

The Canadian Journal of Public Health - Revue Canadienne de Santé Publique, published by Springer International Publishing AG, stands as a pivotal platform for scholarly discourse in the fields of public health and environmental health. With its esteemed position in the Q1 category for both Medicine (miscellaneous) and Public Health, the journal boasts an impressive Scopus ranking that places it within the 80th percentile, reflecting its contribution to advancing knowledge and best practices in public health since its inception in 1945. Situated in Switzerland, this journal serves a global audience of researchers, professionals, and students dedicated to improving public health outcomes. Although it offers traditional access options, its rigorous peer-review process ensures that high-quality research remains at the forefront of its publications. Whether addressing emerging health issues or environmental challenges, the journal plays a vital role in shaping the conversation and policies that influence health systems worldwide.

AIDS Research and Treatment

Empowering research, enhancing treatment.
Publisher: HINDAWI LTDISSN: 2090-1240Frequency: 1 issue/year

AIDS Research and Treatment is a premier open access journal published by HINDAWI LTD, dedicated to advancing the understanding and treatment of HIV/AIDS and related conditions. Launched in 2010, the journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of Dermatology, Immunology, Infectious Diseases, and Public Health. With a notable 2023 impact factor reflected in its Q2 and Q3 quartile rankings across key medical categories, the journal plays a critical role in disseminating high-quality research and fostering innovation in the prevention and treatment of AIDS. It provides a wide range of open access options, enabling easier dissemination and increased visibility of research findings globally. As the landscape of HIV/AIDS research continues to evolve, AIDS Research and Treatment remains at the forefront, ensuring crucial insights and developments are shared to enhance public health outcomes.

Advances in Public Health

Leading the way in public health advancements.
Publisher: HINDAWI LTDISSN: 2356-6868Frequency: 1 issue/year

Advances in Public Health is a distinguished open access journal dedicated to the dissemination of cutting-edge research in the field of public health, published by HINDAWI LTD. Since its inception in 2014, this journal has aimed to foster innovation and facilitate critical discourse on public health challenges, policies, and practices across the globe. With an ISSN of 2356-6868 and an E-ISSN of 2314-7784, it maintains a robust presence in the academic community, featuring prominently with a Scopus rank of #213/665 and proudly residing in the Q2 category within Public Health, Environmental, and Occupational Health as of 2023. Based in Egypt, and serving an international readership, Advances in Public Health provides a platform for researchers, professionals, and students to share their findings and insights, ultimately contributing to the improvement of health outcomes worldwide. Its open access format ensures that valuable research is available to a broader audience, promoting collaboration and knowledge sharing within the public health domain.

Preventive Medicine Reports

Empowering research to transform public health strategies.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Preventive Medicine Reports is a premier open-access journal published by Elsevier, dedicated to advancing the field of preventive medicine and public health. With a focus on innovative research and practices since its inception in 2014, this journal has established itself in the top quartile (Q1) of both Health Informatics and Public Health, Environmental and Occupational Health categories as of 2023. This positions it among the leading publications in its field, showcasing significant contributions to health informatics and public health strategies. The journal's accessibility allows researchers, professionals, and students worldwide to engage with cutting-edge studies that inform health policy and preventive initiatives. By fostering an open exchange of knowledge, Preventive Medicine Reports aims to reduce health disparities and improve population health outcomes, making it an essential resource for anyone invested in the future of health sciences.

Indian Journal of Sexually Transmitted Diseases and AIDS

Pioneering advancements in the fight against STDs and HIV/AIDS.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2589-0557Frequency: 2 issues/year

The Indian Journal of Sexually Transmitted Diseases and AIDS, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, serves as a vital platform for disseminating research and knowledge in the fields of sexually transmitted infections and HIV/AIDS management. With ISSN 2589-0557 and E-ISSN 2589-0565, this journal aims to bridge the gap in public health and clinical research by providing peer-reviewed articles that cover a range of topics from epidemiology to therapeutic advancements. Despite its status with an impact factor in the lower quartiles across relevant categories, including Q3 in Dermatology, Q4 in Infectious Diseases, and Q4 in Public Health, it holds potential for growth and greater visibility within the academic community. The journal's scope spans critical insights and innovative approaches in managing sexually transmitted diseases, and it is committed to fostering scholarly discourse among its readership consisting of researchers, health professionals, and students alike. As it converges from 2018 to 2024, the Indian Journal of Sexually Transmitted Diseases and AIDS continues to underscore the importance of addressing pressing health issues in India and beyond, while offering an accessible resource for those dedicated to this vital field.

Preventive Medicine

Connecting research to real-world health outcomes.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0091-7435Frequency: 12 issues/year

Preventive Medicine is a premier academic journal published by Academic Press Inc Elsevier Science, renowned for its influential contributions to the fields of Epidemiology and Public Health. Since its inception in 1946 and through its dedicated issues leading into 2024, the journal has established itself as a leading platform for cutting-edge research, boasting impressive Scopus rankings, with a notable Q1 status across relevant categories. This journal provides an essential forum for scholars, practitioners, and policy-makers interested in the prevention of diseases and the promotion of health within populations. With each issue, it disseminates valuable insights on preventive strategies, health behaviors, and epidemiological trends, making it crucial for anyone invested in the advancement of public health sciences. The journal does not offer open access options, ensuring that content remains relevant and targeted to its scholarly audience. Given its valuable contributions and recognition in the academic community, Preventive Medicine continues to play a pivotal role in shaping evidence-based approaches to health promotion and disease prevention in modern societal contexts.

Lancet HIV

Innovating solutions for a world affected by HIV.
Publisher: ELSEVIER INCISSN: 2352-3018Frequency: 12 issues/year

The Lancet HIV, published by Elsevier Inc in the United Kingdom, stands at the forefront of HIV research and public health, providing a vital platform for the dissemination of innovative findings and critical knowledge in the fields of epidemiology, immunology, infectious diseases, and virology. With its prestigious Q1 rankings in the aforementioned categories for 2023, the journal is recognized for its significant contribution to advancing understanding and addressing challenges posed by HIV globally. Its impressive standing, including a Scopus ranking in the 94th percentile for multiple categories, underscores its impact within the research community. The Lancet HIV publishes rigorously peer-reviewed research articles, reviews, and opinion pieces, ensuring that all stakeholders—researchers, practitioners, and policymakers—are engaged with up-to-date, evidence-based perspectives. Researchers and students alike will find this journal an invaluable resource for enhancing their knowledge and contributing to the ongoing discourse surrounding HIV treatment and prevention.

Journal of the International AIDS Society

Advancing the Global Fight Against HIV/AIDS
Publisher: JOHN WILEY & SONS LTDISSN: Frequency: 12 issues/year

The Journal of the International AIDS Society, published by John Wiley & Sons Ltd, stands as a premier platform for advancing knowledge in the realms of infectious diseases and public health, boasting a strong Q1 ranking in both categories as of 2023. With its open-access format established since 2004, the journal ensures that groundbreaking research on HIV/AIDS and related issues is widely disseminated and easily accessible to a global audience. This commitment to accessibility significantly enhances its impact factor, making it a vital resource for researchers, practitioners, and students alike who are dedicated to improving health outcomes and understanding the complexities of the epidemic. Covering a diverse range of topics from prevention strategies to health policy, the journal supports its readers in staying at the forefront of public health discourse. With its base in the United States and an impressive Scopus ranking placing it within the top tiers of medical publications, the Journal of the International AIDS Society continues to foster collaboration and innovation in the fight against HIV/AIDS.

Substance Abuse and Rehabilitation

Championing open access to vital addiction research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-8467Frequency: 1 issue/year

Substance Abuse and Rehabilitation, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to the study and treatment of substance abuse and related rehabilitation practices. With its ISSN 1179-8467, this journal provides a vital platform for researchers, clinicians, and students to disseminate their findings and insights in a field increasingly relevant to public health. Since becoming open access in 2010, the journal has enhanced its reach, allowing for a broader audience to engage with cutting-edge research and reviews that address the complexities of substance abuse disorders. The journal aims to foster innovation and interdisciplinary collaboration by publishing high-quality peer-reviewed articles that cover a wide range of topics, including addiction therapy, policy implications, and the social determinants of substance use. As a vital resource within the realm of addiction research, Substance Abuse and Rehabilitation plays a crucial role in driving forward knowledge and practices that can improve outcomes for individuals and communities affected by substance use issues.

HIV Research & Clinical Practice

Advancing knowledge, transforming lives in HIV research.
Publisher: TAYLOR & FRANCIS LTDISSN: 2578-7489Frequency: 6 issues/year

HIV Research & Clinical Practice, published by Taylor & Francis Ltd, is an essential open-access journal dedicated to advancing the knowledge and understanding of HIV-related research and clinical practices. With an ISSN of 2578-7489 and E-ISSN 2578-7470, this acclaimed journal is committed to disseminating cutting-edge studies and innovative treatment strategies within the infectious diseases and pharmacology fields, achieving a commendable Q2 ranking in both categories as of 2023. The journal's scope encompasses a broad range of topics from basic science to clinical application, providing a vital platform for researchers, clinicians, and students to exchange insights and foster collaboration. As an open-access publication since 2022, it ensures that high-quality research is accessible to a global audience, encouraging a greater understanding of HIV and its implications for public health. With its base in the United Kingdom and a convergence period from 2019 to 2024, HIV Research & Clinical Practice stands at the forefront of the fight against HIV/AIDS, making significant contributions to the clinical community and beyond.